First human test of new drug NRS 033 begins
NCT ID NCT05724797
First seen Jan 04, 2026 · Last updated Jun 10, 2026 · Updated 20 times
Summary
This early-stage study tested a new drug called NRS 033 in 24 healthy adults aged 18 to 55. The main goal was to check for side effects and measure how the drug moves through the body. Participants received either a single dose of the drug or a placebo. This study does not aim to treat any disease; it is the first step to see if the drug is safe enough for future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Frontage Clinical Research Center
Secaucus, New Jersey, 07094, United States
Conditions
Explore the condition pages connected to this study.